Carolyn Bertozzi (Noah Berger/AP Images)
September 18, 2023 07:00 AM EDTUpdated 12:26 PM
People

No­bel lau­re­ate Car­olyn Bertozzi joins cell ther­a­py biotech Ace­po­dia as chief sci­en­tif­ic ad­vi­sor

Nicole DeFeudis

Editor

Car­olyn Bertozzi helped kin­dle the spark that be­came cell ther­a­py biotech Ace­po­dia while the com­pa­ny’s co-founder, Son­ny Hsiao, was still a PhD stu­dent, work­ing in …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Pfiz­er look­ing to sell hos­pi­tal drugs unit — re­ports

'Ex­per­tise is a re­al thing': FDA com­mis­sion­er warns of po­lit­i­cal risk to agency

As­traZeneca CEO reaf­firms com­mit­ment to Chi­na fol­low­ing ex­ec­u­tive's de­ten­tion

Mer­ck, As­traZeneca tout Phase 3 win for can­cer-turned-rare dis­ease drug

Sanofi, Ope­nAI, For­ma­tion Bio de­but pa­tient re­cruit­ing tool, will use in Phase 3 mul­ti­ple scle­ro­sis stud­ies

sponsored

What Will It Take to Re­verse Fi­bro­sis in Pa­tients with Ad­vanced MASH?

A service from the Financial Times